Charles J. Homcy, Director at Global Blood Therapeutics, Inc. (GBT), sold 200,000 shares at $26.92 ($5.4M) on 2017-06-02, disclosed to the SEC on 2017-06-22.
Open-market sale of $5.4M GBT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.58 | 18,299 | $486K | 9.0% |
| 2 | $26.58 | 18,299 | $486K | 9.0% |
| 3 | $26.92 | 49,959 | $1.3M | 24.8% |
| 4 | $26.92 | 49,959 | $1.3M | 24.8% |
| 5 | $27.64 | 31,742 | $877K | 16.2% |
| 6 | $27.64 | 31,742 |
| $877K |
| 16.2% |
| Total | $27.09 avg | 200,000 | $5.4M | 100% |
| Filing → |
| BBIO | SELL | 2020-10-01 | $380K | — | Filing → |
| BBIO | SELL | 2020-09-29 | $6.7M | — | Filing → |
| BBIO | SELL | 2020-02-12 | $720K | — | Filing → |